Qiagen N.V. (QGEN) Stock Forecast
QGEN analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.81 / 5 from 16 analysts
- Price target
- $48.13 average of analyst targets
- Upside to target
- +4.3% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.62
- 52-week range
- $32.63 – $55.66
QGEN analyst ratings
16 analystsNumber of analysts at each rating.
QGEN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
QGEN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.62 | $0.61 | $0.64 | $0.64 | −3.4% | 9 |
| Current fiscal year (2026) | $2.43 | $2.42 | $2.45 | $2.38 | +2.3% | 13 |
| Next fiscal year (2027) | $2.61 | $2.57 | $2.71 | $2.43 | +7.3% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
QGEN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $533.9M | $528.3M | $538.3M | +0.2% | 9 |
| Current fiscal year (2026) | $2.14B | $2.12B | $2.15B | +2.2% | 17 |
| Next fiscal year (2027) | $2.24B | $2.21B | $2.29B | +5.1% | 17 |
QGEN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
QGEN revenue: reported and forecast
QGEN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.63 | $0.62 | $0.62 | $0.62 | $0.62 | −1.5% | 1 up · 0 down |
| Current fiscal year (2026) | $2.44 | $2.43 | $2.43 | $2.43 | $2.43 | −0.2% | 1 up · 1 down |
| Next fiscal year (2027) | $2.62 | $2.61 | $2.61 | $2.61 | $2.61 | −0.4% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
QGEN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; QGEN beat in 11 of 12.
What analysts expect from QGEN
16 analysts cover Qiagen; their consensus rating is buy (3.81 on a 1–5 scale, where 5 is a strong buy). The average price target is $48.13, 4.3% above the latest close of $46.13. Analysts expect earnings of $2.43 per share for 2026, +2.3% from a year earlier. For 2027 the average estimate is $2.61 per share on revenue of $2.2 billion. Qiagen beat the EPS estimate in 11 of the last 12 quarters.
Related: QGEN income statement, QGEN key metrics, QGEN chart. See the QGEN stock overview for the latest quote and news.
QGEN forecast FAQ
What is Qiagen's price target?
The average analyst price target for Qiagen is $48.13, 4.3% above the latest close of $46.13.
Is Qiagen a buy, hold or sell?
Of 16 analysts covering Qiagen, 4 rate it a strong buy, 5 a buy, 7 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Qiagen's EPS forecast?
Analysts forecast $2.43 per share for 2026 (range $2.42 to $2.45); for 2027 the estimate is $2.61.
What is Qiagen's revenue forecast?
The average revenue estimate for 2026 is $2.1 billion, growth of 2.2%; for 2027 it is $2.2 billion.
When does Qiagen report earnings?
Qiagen is expected to report results for the quarter ending September 30, 2026 on November 3, 2026; the EPS estimate is $0.62.
Does Qiagen usually beat earnings estimates?
Qiagen reported EPS at or above the analyst estimate in 11 of the last 12 quarters.